Stay updated on BMS-936558 in Advanced Clear-Cell RCC Clinical Trial

Sign up to get notified when there's something new on the BMS-936558 in Advanced Clear-Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-936558 in Advanced Clear-Cell RCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or revision in the data related to the study on BMS-936558 (nivolumab) in subjects with advanced/metastatic clear-cell Renal Cell Carcinoma (RCC). This change may reflect a new finding, adjustment, or development in the research on the effectiveness of the treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:04.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants in the study, specifying requirements such as histologic confirmation of Renal cell carcinoma (RCC) with a clear cell component and previous treatment with at least one anti-angiogenic agent. Previously, the page only listed the dates of the last update submissions and verifications.
    Difference
    13%
    Check dated 2024-05-22T21:26:56.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:52:17.000Z thumbnail image

Stay in the know with updates to BMS-936558 in Advanced Clear-Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-936558 in Advanced Clear-Cell RCC Clinical Trial page.